The Role of GAPDH in the Selective Toxicity of CNP in Melanoma Cells

Treatment of melanoma cells and melanocytes with the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) inhibitor heptelidic acid decreased viability to a much higher extent in the cancer cells than in the studied normal cells.